Dear colleagues,

our goal is to develop new markers for genotyping as well as the new markers linked with the useful traits in rare wild medicine and endemic species. Full genome sequencing is expensive for us. So we just could order the sequencing of the some kind of amplified fragments.

I will be grateful to someone who can share your experience and opinion what is the best way to develop new markers for rare species?

Now we are thinking on ISSR-fragments. But can we sequence the amplified ISSR fragments directly, without cloning into the vector? Or it is better to select other type of fragments for our purpose?

I have read some articles about ISSR-derived SCAR markers, SCoT-markers. But I need someone who can share yours experience in this area.

Thank you in advance,

Kind regards,

Lidia

More Lidia Samarina's questions See All
Similar questions and discussions